{"title":"关于文章“二肽基肽酶-4抑制剂与磺脲类药物作为2型糖尿病附加治疗的心血管结局比较:meta分析”的回复。","authors":"Kyung Woo Park","doi":"10.12997/jla.2022.11.1.87","DOIUrl":null,"url":null,"abstract":"<p><p>[This retracts the article on p. 210 in vol. 10, PMID: 34095013.].</p>","PeriodicalId":16284,"journal":{"name":"Journal of Lipid and Atherosclerosis","volume":"11 1","pages":"87-88"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/fe/jla-11-87.PMC8792815.pdf","citationCount":"0","resultStr":"{\"title\":\"Response to Letter Regarding Article, \\\"Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis\\\".\",\"authors\":\"Kyung Woo Park\",\"doi\":\"10.12997/jla.2022.11.1.87\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This retracts the article on p. 210 in vol. 10, PMID: 34095013.].</p>\",\"PeriodicalId\":16284,\"journal\":{\"name\":\"Journal of Lipid and Atherosclerosis\",\"volume\":\"11 1\",\"pages\":\"87-88\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/fe/jla-11-87.PMC8792815.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Lipid and Atherosclerosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12997/jla.2022.11.1.87\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Lipid and Atherosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12997/jla.2022.11.1.87","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Response to Letter Regarding Article, "Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis".
[This retracts the article on p. 210 in vol. 10, PMID: 34095013.].